May 1, 2012 - OHRIA Notice to the Industry
Horse Racing Industry Information Reception with MPPs at Queen's Park
The evening of Monday, April 30th, OHRIA and Woodbine Entertainment Group (WEG) co-sponsored an Industry Information Reception at Queen's Park in Toronto.
Attended by 58 of Ontario's MPPs, plus some staff, the reception provided OHRIA and WEG the opportunity to personally interact with the members. The evening's focus was to educate and inf..
April 4, 2012 - Notice to the Industry - Clenbuterol testing continues
Testing for clenbuterol in Ontario Quarter Horses continues
Testing for clenbuterol continues this racing season, and will include the lower Ontario Quarter Horse threshold levels introduced last year. This Ontario Racing Commission (ORC) initiative, introduced with the support of the Quarter Racing Owners of Ontario Inc. (QROOI), complements the efforts of the Can..
April 4, 2012 - Notice to the Industry - ORC issues clarification on SB OS
Please find attached a Notice to the Industry issued today by the ORC, clarifying information surrounding the May 15th nomination deadline for the Standardbred Ontario Sires Stakes Program.
For further information, please contact the Program Administrator at 416-213-0520.
March 28, 2012 - COSA - Press Release - Rallies Friday
Liberal MPPs To Be Targeted In Home Ridings on Friday, March 30th - Headcounts are Critical, Please Step Up For The Horse Industry
Liberal MPPs in Ontario are being targeted on Friday, March 30th in an extremely critical concentration of rallies orchestrated by the Ontario Horse Racing Industry Association (OHRIA).
Set for the local constituency offices of many Liberal Members, these events represent our best c..
March 22, 2012 - ORC - Notice to the Industry - Caution and Warning on use of New Substances
The Ontario Racing Commission (ORC) advises all members of the Ontario racing community to use caution when administering substances that may cause a positive test. In particular are those drugs which affect the oxygen-carrying ability of the hemoglobin molecule.
For more information, please review the attached Notice.